Clinical trial
A Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms
NCT04278872 is registered in ClinicalTrials.gov with Sojournix, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms
- Lead sponsor
- Sojournix, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- November 9, 2020
- Completion date
- April 7, 2021
- Enrollment
- 13 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.